Treatment of intracranial human glioblastoma by direct intratumoral administration of 131I-labelled anti-tenascin monoclonal antibody BC-2.

Riva, P

Treatment of intracranial human glioblastoma by direct intratumoral administration of 131I-labelled anti-tenascin monoclonal antibody BC-2. [electronic resource] - International journal of cancer Apr 1992 - 7-13 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0020-7136

10.1002/ijc.2910510103 doi


Adult
Antibodies, Monoclonal--therapeutic use
Antibody Specificity
Brain Neoplasms--radiotherapy
Cell Adhesion Molecules, Neuronal--immunology
Extracellular Matrix Proteins--immunology
Female
Glioma--radiotherapy
Humans
Injections, Intralesional
Iodine Radioisotopes--therapeutic use
Male
Middle Aged
Neoplasm Proteins--immunology
Neoplasm Recurrence, Local--radiotherapy
Radioimmunotherapy
Radiotherapy Dosage
Tenascin